Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation▪

MLA

Lin, Qingxiang, et al. “Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation▪.” The Journal of Pharmacology and Experimental Therapeutics, vol. 377, no. 3, June 2021, pp. 370–84. EBSCOhost, https://doi.org/10.1124/jpet.120.000412.

APA

Lin, Q., Qian, Z., Jusko, W. J., Mager, D. E., Ma, W. W., & Straubinger, R. M. (2021). Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation▪. The Journal of Pharmacology and Experimental Therapeutics, 377(3), 370–384. https://doi.org/10.1124/jpet.120.000412

Chicago

Lin, Qingxiang, Zhicheng Qian, William J. Jusko, Donald E. Mager, Wen Wee Ma, and Robert M. Straubinger. 2021. “Synergistic Pharmacodynamic Effects of Gemcitabine and Fibroblast Growth Factor Receptor Inhibitors on Pancreatic Cancer Cell Cycle Kinetics and Proliferation▪.” The Journal of Pharmacology and Experimental Therapeutics 377 (3): 370–84. doi:10.1124/jpet.120.000412.